Abstract
Information on the rates and predictors of polypharmacy of central nervous system medication in older people with intellectual disability is limited, despite the increased life expectancy of this group. This study examined central nervous system medication use in an older sample of people with intellectual disability.
Original language | English |
---|---|
Pages (from-to) | 352-362 |
Number of pages | 11 |
Journal | Australian & New Zealand Journal of Psychiatry |
Volume | 50 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2016 |
Keywords
- intellectual disability
- challenging behaviour
- central nervous system medication
- polypharmacy